Annual D&A
$3.31 M
-$57.00 K-1.69%
31 December 2023
Summary:
Protagonist Therapeutics annual depreciation & amortization is currently $3.31 million, with the most recent change of -$57.00 thousand (-1.69%) on 31 December 2023. During the last 3 years, it has risen by +$589.00 thousand (+21.63%). PTGX annual D&A is now -1.69% below its all-time high of $3.37 million, reached on 31 December 2022.PTGX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$647.00 K
-$245.00 K-27.47%
30 September 2024
Summary:
Protagonist Therapeutics quarterly depreciation & amortization is currently $647.00 thousand, with the most recent change of -$245.00 thousand (-27.47%) on 30 September 2024. Over the past year, it has dropped by -$180.00 thousand (-21.77%). PTGX quarterly D&A is now -27.47% below its all-time high of $892.00 thousand, reached on 30 June 2024.PTGX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$3.19 M
-$180.00 K-5.34%
30 September 2024
Summary:
Protagonist Therapeutics TTM depreciation & amortization is currently $3.19 million, with the most recent change of -$180.00 thousand (-5.34%) on 30 September 2024. Over the past year, it has dropped by -$129.00 thousand (-3.89%). PTGX TTM D&A is now -5.34% below its all-time high of $3.37 million, reached on 30 June 2024.PTGX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.7% | -21.8% | -3.9% |
| 3 y3 years | +21.6% | -8.1% | +16.2% |
| 5 y5 years | +528.5% | +1.3% | +61.5% |
PTGX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1.7% | +21.6% | -27.5% | at low | -5.3% | +16.2% |
| 5 y | 5 years | -1.7% | +528.5% | -27.5% | +3.7% | -5.3% | +61.5% |
| alltime | all time | -1.7% | +1240.9% | -27.5% | +1220.4% | -5.3% | +5401.7% |
Protagonist Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $647.00 K(-27.5%) | $3.19 M(-5.3%) |
| June 2024 | - | $892.00 K(+8.8%) | $3.37 M(+2.2%) |
| Mar 2024 | - | $820.00 K(-1.4%) | $3.30 M(-0.4%) |
| Dec 2023 | $3.31 M(-1.7%) | $832.00 K(+0.6%) | $3.31 M(-0.2%) |
| Sept 2023 | - | $827.00 K(+0.7%) | $3.32 M(-0.8%) |
| June 2023 | - | $821.00 K(-1.3%) | $3.35 M(-0.7%) |
| Mar 2023 | - | $832.00 K(-1.0%) | $3.37 M(-0.0%) |
| Dec 2022 | $3.37 M(+21.4%) | $840.00 K(-1.5%) | $3.37 M(+0.6%) |
| Sept 2022 | - | $853.00 K(+1.2%) | $3.35 M(+4.7%) |
| June 2022 | - | $843.00 K(+1.2%) | $3.20 M(+7.2%) |
| Mar 2022 | - | $833.00 K(+1.7%) | $2.98 M(+7.5%) |
| Dec 2021 | $2.77 M(+1.9%) | $819.00 K(+16.3%) | $2.77 M(+1.0%) |
| Sept 2021 | - | $704.00 K(+12.1%) | $2.75 M(+2.9%) |
| June 2021 | - | $628.00 K(+0.6%) | $2.67 M(-0.6%) |
| Mar 2021 | - | $624.00 K(-21.1%) | $2.69 M(-1.4%) |
| Dec 2020 | $2.72 M(+7.9%) | $791.00 K(+26.4%) | $2.72 M(+4.4%) |
| Sept 2020 | - | $626.00 K(-2.9%) | $2.61 M(-0.5%) |
| June 2020 | - | $645.00 K(-2.4%) | $2.62 M(+1.0%) |
| Mar 2020 | - | $661.00 K(-2.2%) | $2.60 M(+2.9%) |
| Dec 2019 | $2.52 M | $676.00 K(+5.8%) | $2.52 M(+27.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $639.00 K(+3.1%) | $1.98 M(+32.8%) |
| June 2019 | - | $620.00 K(+5.3%) | $1.49 M(+43.4%) |
| Mar 2019 | - | $589.00 K(+360.2%) | $1.04 M(+97.0%) |
| Dec 2018 | $527.00 K(+29.8%) | $128.00 K(-15.2%) | $527.00 K(+2.1%) |
| Sept 2018 | - | $151.00 K(-11.2%) | $516.00 K(+9.1%) |
| June 2018 | - | $170.00 K(+117.9%) | $473.00 K(+19.4%) |
| Mar 2018 | - | $78.00 K(-33.3%) | $396.00 K(-2.5%) |
| Dec 2017 | $406.00 K(+28.1%) | $117.00 K(+8.3%) | $406.00 K(+11.5%) |
| Sept 2017 | - | $108.00 K(+16.1%) | $364.00 K(+7.4%) |
| June 2017 | - | $93.00 K(+5.7%) | $339.00 K(+2.1%) |
| Mar 2017 | - | $88.00 K(+17.3%) | $332.00 K(+4.7%) |
| Dec 2016 | $317.00 K(+28.3%) | $75.00 K(-9.6%) | $317.00 K(-3.6%) |
| Sept 2016 | - | $83.00 K(-3.5%) | $329.00 K(+11.5%) |
| June 2016 | - | $86.00 K(+17.8%) | $295.00 K(+12.6%) |
| Mar 2016 | - | $73.00 K(-16.1%) | $262.00 K(+6.1%) |
| Dec 2015 | $247.00 K(-4.3%) | $87.00 K(+77.6%) | $247.00 K(+54.4%) |
| Sept 2015 | - | $49.00 K(-7.5%) | $160.00 K(+44.1%) |
| June 2015 | - | $53.00 K(-8.6%) | $111.00 K(+91.4%) |
| Mar 2015 | - | $58.00 K | $58.00 K |
| Dec 2014 | $258.00 K | - | - |
FAQ
- What is Protagonist Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual D&A year-on-year change?
- What is Protagonist Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly D&A year-on-year change?
- What is Protagonist Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Protagonist Therapeutics?
- What is Protagonist Therapeutics TTM D&A year-on-year change?
What is Protagonist Therapeutics annual depreciation & amortization?
The current annual D&A of PTGX is $3.31 M
What is the all time high annual D&A for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual depreciation & amortization is $3.37 M
What is Protagonist Therapeutics annual D&A year-on-year change?
Over the past year, PTGX annual depreciation & amortization has changed by -$57.00 K (-1.69%)
What is Protagonist Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of PTGX is $647.00 K
What is the all time high quarterly D&A for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly depreciation & amortization is $892.00 K
What is Protagonist Therapeutics quarterly D&A year-on-year change?
Over the past year, PTGX quarterly depreciation & amortization has changed by -$180.00 K (-21.77%)
What is Protagonist Therapeutics TTM depreciation & amortization?
The current TTM D&A of PTGX is $3.19 M
What is the all time high TTM D&A for Protagonist Therapeutics?
Protagonist Therapeutics all-time high TTM depreciation & amortization is $3.37 M
What is Protagonist Therapeutics TTM D&A year-on-year change?
Over the past year, PTGX TTM depreciation & amortization has changed by -$129.00 K (-3.89%)